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Introduction: Patients with severe acute kidney injury (AKI) who are hospitalized at centers that do not provide
renal replacement therapy (RRT) are frequently subjected to inter-hospital transfer for the provision of RRT. It is
unclear whether such transfers are associated with worse patient outcomes as compared with the receipt of initial
care in a center that provides RRT. This study examined the relationship between inter-hospital transfer and 30-day
mortality among critically ill patients with AKI who received RRT.
Methods: We conducted a retrospective cohort study of all critically ill patients who commenced RRT for AKI at two
academic hospitals in Toronto, Canada. The exposure of interest was inter-hospital transfer for the administration of RRT.
We evaluated the relationship between transfer status and 30-day mortality (primary outcome) and RRT dependence at
30 days following RRT initiation (secondary outcome), by using multivariate logistic regression with adjustment for
patient demographics, clinical factors, biochemical indices, and severity of illness.
Results: Of 370 patients who underwent RRT for AKI, 82 (22.2%) were transferred for this purpose from another
hospital. Compared with non-transferred patients who started RRT, transferred patients were younger (61 ± 15 versus
65 ± 15 years, P = 0.03) and had a higher serum creatinine concentration at RRT initiation (474 ± 295 versus 365 ± 169
μmol/L, P = 0.002). Inter-hospital transfer was not associated with mortality (adjusted odds ratio 0.61, 95% confidence
interval 0.33 to 1.12) or RRT-dependence (adjusted odds ratio 1.64, 95% confidence interval 0.70 to 3.81) at 30 days.
Conclusions: Within the limitations of this observational study and the potential for residual confounding, inter-hospital
transfer of critically ill patients with AKI was not associated with a higher risk of death or dialysis dependence 30 days after
the initiation of acute RRT.Introduction
Acute kidney injury (AKI) requiring renal replacement
therapy (RRT) occurs in approximately 3% to 10% of pa-
tients admitted to the intensive care unit (ICU) and is
associated with short-term mortality in excess of 50%
[1,2]. Since some hospitals may not have RRT capability,
patients with severe AKI often require transfer to cen-
ters that offer RRT. Transfers may delay initiation of
RRT and this conceivably could adversely impact upon* Correspondence: waldr@smh.ca
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unless otherwise stated.outcomes [3]. Several large-scale studies have evaluated
the association between inter-hospital transfer and out-
comes among diverse populations of critically patients
[4-7]. It remains unclear whether delays in care and the
transfer process itself are mediators of adverse outcomes
or whether heightened mortality among transferred pa-
tients is merely the result of confounding by acute illness
or chronic comorbidity or both. In the specific setting of
severe AKI, in which the application of renal support may
directly treat and reverse some of the metabolic complica-
tions of this condition, it is plausible that delays associated
with transfer can lead to worse outcomes. At present,
there are no data on the impact of inter-hospital transfer
on outcomes of critically ill patients with AKI who
received RRT.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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to examine the relationship between inter-hospital transfer
and 30-day mortality among critically ill patients with AKI
who initiated RRT. We hypothesized that patients who
were initially admitted to a facility that did not provide
RRT and were subsequently transferred to another hos-
pital for the provision of RRT would have higher mortality
and a higher risk of RRT dependence compared with indi-
viduals with RRT requiring AKI who commenced their
hospitalization at centers with on-site RRT capability.
Materials and methods
Study design and datasets
This was a retrospective cohort study that comprised all
patients who commenced RRT for AKI in an ICU setting
at two academic medical centers in Toronto, Canada: St.
Michael’s Hospital (April 2007 to December 2010) and
Sunnybrook Health Sciences Centre (January to December
2010). We excluded patients with pre-existing end-stage
renal disease, patients dialyzed solely for toxin removal, and
transferred patients who commenced RRT at another
hospital. The research ethics boards at both St. Michael’s
Hospital and Sunnybrook Health Science Centre approved
the protocol and waived the need for written informed
consent. Written informed consent was waived because the
study was retrospective with no potential for harm to sub-
jects. All information was collected in an anonymized data-
base, thereby ensuring patient privacy during the analyses.
Data collection
Data were collected in a standardized fashion by trained
data collectors using a Microsoft Access 2003 (Microsoft
Corporation, Redmond, WA, USA) database. Inter-hospital
transfer status and demographic, clinical, physiologic, and
laboratory details were collected on the day of initial hos-
pital admission, transfer to study hospital (if relevant), ICU
admission at the study hospital, and RRT initiation. The
burden of pre-existing chronic illness was assessed with the
Charlson comorbidity index [8]. Severity of acute illness
was recorded by using the modified Sequential Organ
Failure Assessment (SOFA) score [9] calculated on the
day of RRT initiation (Additional file 1). Relevant la-
boratory data were recorded on admission to hospital,
admission to the ICU, and the day of RRT initiation,
where available. Although premorbid kidney function
was evaluated by using the estimated glomerular filtra-
tion rate (eGFR) as derived from the abbreviated Modi-
fication of Diet in Renal Disease (MDRD) formula [10],
significant data were missing. The serum creatinine
(sCr) value used for this calculation was the pre-
hospitalization value closest to the day of admission but
no more than 1 year prior to admission. When a pre-
hospitalization sCr value was not available, the first sCr
measured on admission to the hospital served as thebaseline sCr. We documented blood pressure and vaso-
pressor requirements at the start of RRT. The initial RRT
modality was categorized as intermittent hemodialysis
(prescribed treatment duration of less than 6 hours), sus-
tained low-efficiency dialysis (prescribed treatment dur-
ation of more than 6 hours), or continuous RRT.
Definition of exposure: transfer status
We defined patients as “transferred” if their hospitalization
commenced at a different center and RRT was initiated
within 2 calendar days of arrival at the study hospital. We
chose this cutoff in order to define a cohort of patients in
whom AKI and specifically the associated need for RRT
were the driving stimuli for patient transfer. Patients ad-
mitted directly to the study hospitals where RRT com-
menced were considered “non-transfers”. Patients whose
hospitalization commenced at a different center and
started RRT of more than 2 days after transfer were in-
cluded in the “non-transfer” group for the primary analysis
as it is likely that the need for RRT was not the primary
reason for their transfer. We performed two pre-specified
sensitivity analyses to test the appropriateness of this as-
sumption by (a) analyzing patients who commenced RRT
of more than 2 days after transfer as a separate (third)
group and (b) excluding such patients completely.
Outcomes
The primary outcome was all-cause mortality, and the
secondary outcome was dialysis dependence, both evalu-
ated at 30 days after RRT initiation. Renal recovery was
further described as complete, partial, or absent at 30
days following acute RRT initiation. Absent recovery
was defined as persistent dialysis dependence. Complete
recovery was defined as a return of the sCr to within 27
μmol/L of the initial baseline and not exceeding 1.5
times this value. In cases in which no pre-hospitalization
baseline sCr was unavailable, an eGFR of more than 60
mL/min per 1.73 m2 30 days after RRT initiation was
considered to be complete recovery. RRT-independent
patients who did not meet criteria for complete recovery
were classified as having a partial recovery. In cases in
which no follow-up sCr value was measured at 30 days,
the last measured sCr was carried forward for the pur-
poses of defining renal recovery. Finally, in the absence
of follow-up data, if a patient was discharged from the
study with an ongoing need for RRT but prior to 30 days
after RRT initiation, we assumed the patient was still
RRT-dependent on day 30.
Statistical analyses
Descriptive statistics were used to compare baseline
characteristics, clinical variables, and outcomes at 30
days among transferred versus non-transferred patients.
Normally distributed continuous variables are described
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using the Student t test. Variables that were not normally
distributed were compared by using the Kruskal-Wallis
test. Categorical variables were compared by using the
chi-square or Fisher exact tests. Multivariable logistic re-
gression was used to identify the independent association
between transfer status and the outcomes of interest after
adjustment for potential confounders of this relationship
(that is, age, sex, ICU type, Charlson score, SOFA score,
selected features of clinical history, and laboratory values).
These variables were selected due to clinical relevance. A
P value of less than 0.05 was considered statistically sig-
nificant. We performed all analyses by using SAS software
version 9.4 (SAS Institute Inc., Cary, NC, USA).
Results
Baseline characteristics of the cohort
We identified 383 critically ill patients who received RRT
for AKI during the study period (325 at St. Michael’s Hos-
pital and 58 at Sunnybrook Health Sciences Centre).
Thirteen patients were excluded as RRT was initiated at
a different hospital prior to transfer to the study hos-
pital. Of the remaining 370 patients, 82 (22.2%) were
transferred and commenced RRT within 2 days of trans-
fer, 78 were transferred but started RRT more than 2
days after transfer, and 210 were admitted directly to
the study hospital at which RRT commenced (Figure 1).
The 288 patients in the latter two groups were categorized
as “non-transferred” as previously specified. Transferred
patients were younger than non-transferred patients (61 ±Figure 1 Assembly of the study cohort.15 versus 65 ± 15 years, P = 0.03) and were more likely to
have a medical diagnosis, to be managed in a general
medical-surgical ICU, and to have worse kidney function
on admission (Table 1). At the time of RRT initiation
(Table 2), transferred patients had a significantly higher
sCr (474 ± 295 versus 365 ± 169 μmol/L among non-
transferred patients, P = 0.002) and a shorter interval
from admission to RRT initiation (median 3, interquar-
tile range (IQR) 1 to 7 versus 7, IQR 3 to 15 days among
non-transferred patients, P <0.0001).
Outcomes
There was no statistically significant difference in crude
30-day mortality between transferred and non-transferred
patients (42.7% versus 52.1%, respectively, P = 0.13).
Among surviving patients, the likelihood of full kidney
recovery was lower and the probability of persistent RRT
dependence was higher among transferred patients
(P = 0.02) (Table 3).
Multivariable analyses
After confounders were accounted for, there was no asso-
ciation between inter-hospital transfer and 30-day mortal-
ity (adjusted odds ratio (OR) 0.61, 95% confidence interval
(CI) 0.33 to 1.12 versus non-transferred patients). In the
fully adjusted model, the only significant predictors of 30-
day mortality were SOFA score (OR 1.19, 95% CI 1.09 to
1.31 per 1-point increase) and Charlson score (OR 1.15,
95% CI 1.03 to 1.28 per 1-point increase) at baseline
(Table 4). Inter-hospital transfer was not independently






Median days from initial admission to RRT start at study hospital (interquartile range) 3 (1-7) 7 (3-15) <0.0001
First RRT modality
Intermittent hemodialysis 36 (43.9) 123 (42.7) 0.32
Continuous RRT 32 (39.0) 132 (45.8)
Sustained low-efficiency dialysis 14 (17.1) 33 (11.5)
Sequential Organ Failure Assessment score 14.4 (4.5) 14.2 (4.4) 0.70
Mechanical ventilation 64 (78) 229 (80) 0.77
Receipt of vasopressors 49 (60) 142 (49) 0.09
Systolic blood pressure, mm Hg 115 (22) 116 (23) 0.58
Serum creatinine, μmol/L 474 (295) 365 (169) 0.002
Urine output, mL/24 hours 396 (686) 479 (721) 0.35
Hemoglobin, g/L 91.0 (19.6) 87.0 (17.4) 0.07
White blood cell count, ×109/L 14.3 (7.3) 15.8 (12.5) 0.17
Serum potassium, mmol/L 4.8 (1.0) 4.7 (0.9) 0.30
Serum bicarbonate, mmol/L 17.6 (5.7) 19.0 (5.4) 0.04
pH 7.27 (0.12) 7.30 (0.11) 0.05
Continuous variables are presented as means (standard deviation) or median (Q1-Q3) and categorical variables as number (percentage). pH data missing for three
transferred and 37 non-transferred patients. RRT, renal replacement therapy.






Age, years 61 (15) 65 (15) 003
Male sex 49 (60) 187 (65) 0.39
sCr, μmol/L
On admission 334.1 (358.9) 195.1 (187.0) 0.0013
At time of nephrology consult 459.3 (312.1) 291.9 (169.9) <0.0001
On admission to the ICU 452.2 (325.8) 214.7 (185.5) <0.0001
BUN, mmol/L
On admission 19.1 (17.3) 14.6 (12.0) 0.04
On admission to the ICU 24.4 (14.6) 16.1 (12.4) <0.0001
Diagnostic category <0.001
Medical 55 (67) 113 (39)
Surgical 27 (33) 175 (60)
Cardiac surgery 5 (6.1) 65 (22.6) 0.0008
Abdominal aortic aneurysm repair 3 (3.7) 22 (7.6) 0.32
ICU type 0.002
Medical-surgical 66 (80.5) 179 (62.2)
Coronary care 8 (9.8) 31 (10.8)
Cardiovascular surgery 7 (8.5) 2 (0.7)
Burn unit 1 (1.2) 76 (26.4)
Charlson comorbidity index 2.7 (2.5) 2.7 (2.4) 0.78
Continuous variables are presented as means (standard deviation) unless otherwise specified and categorical variables as number (percentage). BUN, blood urea
nitrogen; ICU, intensive care unit; sCr, serum creatinine.
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Table 3 Unadjusted outcomes at 30 days following






Mortality, n (%) 35 (42.7) 150 (52.1) 0.13
Kidney status among
survivors, n (%)
Full recovery 6 (12.8) 46 (33.3) 0.02
Partial recovery 20 (42.6) 42 (30.4)
Renal replacement
therapy-dependent
21 (44.7) 50 (36.2)
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OR 1.64, 95% CI 0.70 to 3.81) (Additional file 2). There
were no independent significant predictors of dialysis de-
pendence at 30 days.
Sensitivity analyses
We examined the influence of patients who commenced
RRT more than 2 days after transfer (who were consid-
ered to be non-transferred in the primary analysis) on
the robustness of our main results. We first analyzed
these patients in their own category. After adjustment
for confounders, transferred patients who commenced
RRT within 2 days of transfer (adjusted OR 0.69, 95% CI
0.37 to 1.28) and those who commenced RRT more
than 2 days after transfer (adjusted OR 1.82, 95% CI
0.96 to 3.46) did not have a higher adjusted 30-day mor-
tality when compared with patients admitted directly toTable 4 The association between transfer status and 30-day m
Univariate
odds ratio (95% CI)
Transferred 0.69 (0.42-1.12)
Age, per year 1.00 (0.99-1.02)
Male 1.15 (0.75-1.76)
Surgical 0.88 (0.58-1.32)
Cardiac surgery 0.70 (0.42-1.19)
Post-AAA repair 0.54 (0.23-1.26)
Charlson score, per unit 1.08 (0.99-1.17)
Variables at the start of renal replacement therapy
SOFA score, per unit 1.22 (1.16-1.29)
Mechanical ventilation 2.50 (1.47-4.25)
Vasopressors 3.41 (2.23-5.23)
Systolic blood pressure, per 10 mm Hg 0.79 (0.72-0.88)
sCr, per 50 μmol/L 0.86 (0.81-0.92)
Urine output, per 100 mL/day 0.99 (0.96-1.02)
Hemoglobin, per g/L 1.00 (0.98-1.01)
White blood cell count, per 1 × 109 cells/L 1.00 (0.99-1.02)
Serum bicarbonate, per mmol/L 0.96 (0.92-1.00)
AAA, abdominal aortic aneurysm; CI, confidence interval; sCr, serum creatinine; SOFthe study centers (“true” non-transferred patients)
(Additional file 3). In a second sensitivity analysis, we
excluded patients who commenced RRT of more than 2
days after transfer; the lack of association between
inter-hospital transfer and 30-day mortality was consist-
ent with the findings of the primary analysis (adjusted
OR 0.68, 95% CI 0.36 to 1.28) (Additional file 4).
Discussion
Critically ill patients who required inter-hospital transfer
for the receipt of RRT, compared with patients who were
admitted directly to the hospital at which RRT com-
menced, did not have a higher risk of 30-day mortality or
RRT dependence. This is despite the fact that transferred
patients commenced RRT with a higher sCr, suggesting
that this group either had a higher prevalence of chronic
kidney disease at baseline or initiated RRT when AKI was
more advanced.
To the best of our knowledge, this is the first study to
examine the impact of inter-hospital transfer on clinical
outcomes among critically ill patients with AKI who re-
ceived RRT. Our findings do not support the initial hypoth-
esis that patients subjected to inter-hospital transfer in the
context of severe AKI would have inferior outcomes com-
pared with individuals who were admitted directly to a cen-
ter at which RRT could be administered. Crude mortality
was actually lower among patients who were transferred for
RRT, an association that was attenuated to become statisti-
cally non-significant with adjustment for key confounders.ortality
P value Multivariable
odds ratio (95% CI)
P value
0.13 0.61 (0.33-1.12) 0.11
0.48 1.02 (1.00-1.04) 0.02
0.52 1.34 (0.79-2.25) 0.27
0.53 0.91 (0.52-1.59) 0.73
0.19 0.52 (0.26-1.03) 0.06
0.15 0.47 (0.17-1.29) 0.14
0.11 1.15 (1.03-1.28) 0.01
<0.0001 1.19 (1.09-1.31) 0.0001
0.0007 0.82 (0.40-1.69) 0.59
<0.0001 1.25 (0.68-2.32) 0.47
<0.0001 0.87 (0.78-0.98) 0.03
<0.0001 0.91 (0.84-0.98) 0.01
0.36 1.01 (0.97-1.04) 0.69
0.41 1.00 (0.99-1.01) 0.94
0.75 0.99 (0.97-1.01) 0.39
0.03 0.98 (0.94-1.03) 0.37
A, Sequential Organ Failure Assessment.
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adverse events and the theoretical risk of clinical in-
stability during transport [11,12]. These factors are
compounded by data suggesting that delays in nephrol-
ogy consultation and RRT initiation in hospitalized pa-
tients with AKI are associated with inferior clinical
outcomes [3,13-16]. Although the controversy sur-
rounding the timing of RRT initiation in AKI generally
assumes that RRT is available on-site and that clinician
decision-making is the main factor that determines tim-
ing of RRT initiation, the lack of RRT capability at many
hospitals in Ontario presented a natural setting in which
to study the effects of delayed initiation of RRT in the
setting of AKI. Although a definitive trial in this area is
needed, the current findings suggest that the ability to
provide “urgent” RRT by either expanding local RRT
capabilities or by accelerated transfer policies may not
improve survival.
This is the first study to evaluate the impact of trans-
ferring patients with AKI and can be interpreted in the
context of studies that examined the transfer of critic-
ally ill patients in other settings. A prospective cohort
study [4] (n = 4,208) found that, compared with directly
admitted patients, ICU patients transferred from an-
other hospital had significantly higher acute physiology
scores at the time of admission and discharge. Even
after full adjustment for severity of illness, transferred
patients had prolongation of ICU and hospital stays by
38% and 41%, respectively, and a greater than twofold
higher risk of hospital mortality than directly admitted
patients [4]. Increased mortality and length of stay
among transferred patients have been described in other
observational studies [5,6]. In contrast, a propensity-
matched cohort study (n = 2,277) found that patients
transferred between ICUs at two different hospitals for
non-clinical reasons stayed on average 3 days longer in
ICU compared with matched non-transferred patients,
but there was no difference in mortality [7]. Overall,
the impact of inter-hospital transfer on clinical out-
comes is inconclusive and may depend on the context
(that is, clinical versus logistic reasons for inter-
hospital transfer).
This study has several strengths. Our cohort com-
prised critically ill patients from two urban tertiary care
centers that frequently accept critically ill patients
through a government-administered network that en-
sures the timely transfer of patients with specialized
medical needs that cannot be met at the hospital to
which they are admitted (for example, RRT). The study
was set in a large province with many hospitals, some of
which were remote from urban centers and do not pro-
vide RRT. As a result, our study addresses a challenge
relevant to any health-care system providing care in a
geographically large territory. We minimized bias byadjusting for several crucial confounders of the relation-
ship between inter-hospital transfer and the outcomes
of interest.
There are, however, important limitations to consider.
Although there were no obvious differences between the
transferred and non-transferred patients with respect to
demographics or severity of illness, one must consider
the very real possibility of residual confounding. For ex-
ample, patients who underwent inter-hospital transfer
may have been perceived as clinically healthier and thus
able to withstand the transfer safely. As a result, the sub-
set of individuals who were transferred may not reflect
the population of patients at the sending hospital in
whom transfer was not considered; had they been admit-
ted initially to a hospital that provided RRT, they may
have been offered RRT. This immortal time bias, as well
as indication bias, may explain the trend toward im-
proved survival among patients subjected to inter-
hospital transfer. Secondly, our dataset does not provide
information on the distance from the initial admitting
hospital to the RRT-providing center and the travel time
associated with the inter-hospital transfer. Some patients
may have experienced more delays relative to others be-
cause of inter-hospital transfer, and we could not ad-
equately capture this. The relatively small sample size
may have also limited our statistical power to detect a
significant association between transfer and clinical out-
comes, and future studies with larger sample sizes will
be needed to further clarify this question. Furthermore,
we could not readily document the precise rationale for
transfer in each case. As a result, we applied a somewhat
arbitrary definition for the main exposure of “transfer
status” that considered the patient to be transferred if he
or she started RRT for AKI within two days of arriving
at the RRT facility. We reasoned that if RRT was not
started within two days of an inter-hospital transfer, the
need for RRT was unlikely to be an important factor in
the transfer of the patient. It is reassuring that our sensi-
tivity analyses demonstrated that alternative ways of
classifying this scenario did not affect the main results.Conclusions
Transfer of patients for the receipt of specialized medical
care is an important public health issue with resource
ramifications. Our findings suggest that patients with
AKI who required inter-hospital transfer for the initi-
ation of RRT did not have inferior clinical outcomes. Al-
though this question would benefit from further study in
larger cohorts and with consideration of AKI patients who
are not transferred, the current data does not support the
investment of resources to ensure the widespread estab-
lishment of RRT capability simply to mitigate the need for
patient transfer.
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 To the best of our knowledge, this is the first study
to examine the impact of inter-hospital transfer on
clinical outcomes among critically ill patients with
AKI who received RRT.
 Within the limitations of this observational study and
the potential for residual confounding, inter-hospital
transfer of critically ill patients with AKI was not
associated with a higher risk of death or dialysis
dependence 30 days after the initiation of acute RRT.
Additional files
Additional file 1: Modified Sequential Organ Failure Assessment
(SOFA) score. Patients were given a SOFA score (total 0 to 24).
Additional file 2: The association between transfer status and
dialysis-dependence at 30 days among surviving patients.
Additional file 3: Sensitivity analysis. The adjusted association
between transfer status and 30-day mortality while considering patients
who received renal replacement therapy (RRT) more than 2 days after
transfer in a separate category is shown.
Additional file 4: Sensitivity analysis. The adjusted association
between transfer status and 30-day mortality after excluding transferred
patients who commenced renal replacement therapy (RRT) more than 2
days after transfer is shown.
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